Pier Capital’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-301,171
Closed -$4.37M 137
2025
Q3
$4.37M Sell
301,171
-13,625
-4% -$196K 0.68% 74
2025
Q2
$4.4M Sell
314,796
-20,708
-6% -$291K 0.67% 73
2025
Q1
$4.56M Buy
335,504
+3,185
+1% +$61K 0.76% 65
2024
Q4
$6.77M Buy
332,319
+164,237
+98% +$4.2M 0.97% 66
2024
Q3
$4.9M Buy
168,082
+2,596
+2% +$64.3K 0.69% 81
2024
Q2
$3.84M Sell
165,486
-6,845
-4% -$131K 0.57% 86
2024
Q1
$3.54M Sell
172,331
-1,888
-1% -$35.5K 0.49% 89
2023
Q4
$3.74M Buy
174,219
+49,139
+39% +$973K 0.53% 87
2023
Q3
$2.58M Sell
125,080
-2,048
-2% -$51.9K 0.42% 91
2023
Q2
$3.75M Buy
+127,128
New +$3.57M 0.54% 89

Other funds holding DNLI